Compare Crispr Therapeutics AG (CRSP) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Unity Software Inc — how do they compare? Crispr Therapeutics AG trades at $53.37 (market cap $4.88B), while Unity Software Inc trades at $46.88 (market cap $20.20B). The key difference: Unity Software Inc is far larger — about 4.1× Crispr Therapeutics AG's market cap, and Unity Software Inc is trading nearer its 52-week high, Crispr Therapeutics AG nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Crispr Therapeutics AG for 77 Days and Unity Software Inc for 50 Days on average.
| CRSP | U | |
|---|---|---|
Market Cap | $4.88B | $20.20B |
Volume | 2,861,747 | 15,432,191 |
Sector | Health | Technology |
52-Week High | $74.92 | $49.47 |
52-Week Low | $44.34 | $17.13 |
Typical Hold Time | 77 Days | 50 Days |
Enterprise Value | $3.30B | $20.08B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRISPR Therapeutics (CRSP) trades at $53.39, up 1.99% on the day, but remains in a bearish technical trend. The company shows no revenue in 2025, with significant losses (net income margin -4,101.26%) and negative cash flow from operations. However, analyst sentiment is positive with a 57.9% buy rating and a $67.83 consensus price target, citing upcoming clinical data catalysts for its gene-editing therapies like CASGEVY and zugo-cel.
The outlook hinges on successful clinical execution and commercialization of its pipeline. Near-term catalysts include data readouts in autoimmune diseases, but high cash burn, intense competition, and regulatory risks pose substantial challenges. The stock offers high-risk, high-reward potential for investors betting on gene-editing breakthroughs.
Unity Software (U) trades at $46.88, up 3.17% on the day, with a bullish technical outlook supported by moving averages and a consensus price target of $46.54. The company reported revenue of $1.85 billion for 2025, with improving net loss margins from -66.22% in 2022 to -21.78% in 2025. Recent news highlights momentum from Meta VR Glasses support and positive analyst coverage, though the stock shows overbought RSI signals near-term.
The stock presents a growth opportunity driven by strategic revenue expansion and margin improvements, but carries risks from persistent net losses, high valuation multiples, and competitive pressures in the gaming engine market. Institutional ownership trends and insider sales require monitoring for sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
